Skip to main content

Alymsys 100 mg/4 mL (25 mg/mL) vial Images

Generic Name: bevacizumab

This medication has been identified as Alymsys 100 mg/4 mL (25 mg/mL) vial. It is supplied by Amneal Pharmaceuticals LLC.

Alymsys is used in the treatment of Colorectal Cancer; Glioblastoma Multiforme; Cervical Cancer; Fallopian Tube Cancer; Non Small Cell Lung Cancer and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Alymsys 100 mg/4 mL (25 mg/mL) vial is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Alymsys 100 mg/4 mL (25 mg/mL) vial medicine

Alymsys

Generic Name
bevacizumab
Strength
100 mg/4 mL (25 mg/mL) vial
Availability
Prescription only
Drug Class
VEGF/VEGFR inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals LLC
National Drug Code (NDC)
70121-1754

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.